Hong Kong Stocks End in Green; Junshi Bio Gains 3%

MT Newswires Live
09/08

Hong Kong stocks ended higher Monday as markets analyzed the latest trade data from China and investors factored in a chance of a major rate cut in the U.S.

The Hang Seng Index gained 215.93 points, or 0.9%, to 25,633.91, while the Hang Seng China Enterprises Index rose 64.44 points, or 0.71%, to 9,121.66.

China's exports jumped by 4.4% in August, while imports rose by 1.3%, according to official data. The figures missed the respective 5% and 3% growth predicted by analysts polled by Reuters.

Meanwhile, markets increasingly expected the Federal Open Market Committee to cut rates next week after the U.S. reported dismal labor data, Reuters reported.

In corporate news, Hesai Group (HKG:2525) launched its initial public offering in Hong Kong, seeking to raise as much as HK$3.88 billion from the deal.

The three-dimensional light detection developer is offering up to 17 million shares at an indicative price of HK$228.00 apiece, according to an filing with the Hong Kong Exchange.

Elsewhere, Shanghai Junshi Biosciences (HKG:1877, SHA:688180) said its experimental dermatology drug JS005 achieved "positive results" in a phase 3 clinical trial.

Shares closed nearly 3% higher.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10